Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy

Susanna Esposito*, Gayatri Amirthalingam, Matteo Bassetti, Francesco Blasi, Francesco Giuseppe De Rosa, Natasha B. Halasa, Ivan Hung, Albert Osterhaus, Tina Tan, Juan Pablo Torres, Antonio Vena, Nicola Principi

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

INIS

Immunology and Microbiology